APLS
Price
$27.52
Change
-$0.83 (-2.93%)
Updated
Feb 21 closing price
Capitalization
3.42B
6 days until earnings call
INZY
Price
$1.25
Change
-$0.02 (-1.57%)
Updated
Feb 21 closing price
Capitalization
80.3M
26 days until earnings call
Ad is loading...

APLS vs INZY

Header iconAPLS vs INZY Comparison
Open Charts APLS vs INZYBanner chart's image
Apellis Pharmaceuticals
Price$27.52
Change-$0.83 (-2.93%)
Volume$1.34M
Capitalization3.42B
Inozyme Pharma
Price$1.25
Change-$0.02 (-1.57%)
Volume$705.24K
Capitalization80.3M
APLS vs INZY Comparison Chart
Loading...
APLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APLS vs. INZY commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APLS is a Hold and INZY is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (APLS: $27.52 vs. INZY: $1.25)
Brand notoriety: APLS and INZY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APLS: 76% vs. INZY: 93%
Market capitalization -- APLS: $3.42B vs. INZY: $80.3M
APLS [@Biotechnology] is valued at $3.42B. INZY’s [@Biotechnology] market capitalization is $80.3M. The market cap for tickers in the [@Biotechnology] industry ranges from $369.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APLS’s FA Score shows that 0 FA rating(s) are green whileINZY’s FA Score has 1 green FA rating(s).

  • APLS’s FA Score: 0 green, 5 red.
  • INZY’s FA Score: 1 green, 4 red.
According to our system of comparison, INZY is a better buy in the long-term than APLS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APLS’s TA Score shows that 4 TA indicator(s) are bullish while INZY’s TA Score has 4 bullish TA indicator(s).

  • APLS’s TA Score: 4 bullish, 5 bearish.
  • INZY’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, INZY is a better buy in the short-term than APLS.

Price Growth

APLS (@Biotechnology) experienced а +0.44% price change this week, while INZY (@Biotechnology) price change was -8.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.71%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +0.86%.

Reported Earning Dates

APLS is expected to report earnings on May 01, 2025.

INZY is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-1.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APLS($3.42B) has a higher market cap than INZY($80.3M). APLS YTD gains are higher at: -13.757 vs. INZY (-54.874). INZY has higher annual earnings (EBITDA): -90.3M vs. APLS (-209.71M). APLS has more cash in the bank: 397M vs. INZY (132M). INZY has less debt than APLS: INZY (46.8M) vs APLS (470M). APLS has higher revenues than INZY: APLS (715M) vs INZY (0).
APLSINZYAPLS / INZY
Capitalization3.42B80.3M4,263%
EBITDA-209.71M-90.3M232%
Gain YTD-13.757-54.87425%
P/E RatioN/AN/A-
Revenue715M0-
Total Cash397M132M301%
Total Debt470M46.8M1,004%
FUNDAMENTALS RATINGS
APLS: Fundamental Ratings
APLS
OUTLOOK RATING
1..100
62
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
84
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APLSINZY
RSI
ODDS (%)
Bullish Trend 5 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend about 1 month ago
87%
Declines
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
APLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PM154.402.83
+1.87%
Philip Morris International
SKIL27.53-0.20
-0.72%
Skillsoft Corp
ENLT17.82-0.20
-1.11%
Enlight Renewable Energy Ltd
OSUR3.80-0.08
-2.06%
OraSure Technologies
NXT46.12-2.30
-4.75%
Nextracker

APLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, APLS has been loosely correlated with INZY. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if APLS jumps, then INZY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APLS
1D Price
Change %
APLS100%
-2.93%
INZY - APLS
39%
Loosely correlated
-1.57%
IGMS - APLS
39%
Loosely correlated
-0.72%
CRSP - APLS
37%
Loosely correlated
-5.00%
ROIV - APLS
37%
Loosely correlated
-0.37%
NTLA - APLS
37%
Loosely correlated
-0.65%
More

INZY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INZY has been loosely correlated with IGMS. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if INZY jumps, then IGMS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INZY
1D Price
Change %
INZY100%
-1.57%
IGMS - INZY
51%
Loosely correlated
-0.72%
MRSN - INZY
47%
Loosely correlated
+0.98%
BEAM - INZY
45%
Loosely correlated
-8.18%
THRD - INZY
44%
Loosely correlated
-3.07%
ERAS - INZY
44%
Loosely correlated
-3.42%
More